PMC5694564_01
Fundus photography of the right (a) and left (b) eyes demonstrating multiple posterior small variably pigmented lesions consistent with punctate inner choroidopathy.
CRIOPM2017-4754231.001.jpg
PMC5694564_01_CRIOPM2017-4754231.001.jpg
fig1
Fundoscopic exam revealed multiple, small, punched-out variably pigmented lesions in the posterior pole of both eyes with scattered peripheral lesions (Figure 1).
(a) Right eye optical coherence tomography revealing retinal pigment epithelium disruption and elevation and subretinal deposition with intraretinal cystic changes. (b) Left eye optical coherence tomography revealing retinal pigment epithelium disruption with associated subretinal and intraretinal fluid.
CRIOPM2017-4754231.002.jpg
PMC5694564_01_CRIOPM2017-4754231.002.jpg
fig2
OCT, Heidelberg Engineering, Inc., Heidelberg, Germany) demonstrated RPE disruption and deposition with intraretinal fluid with retinal atrophy in the right eye (Figure 2(a)) and RPE disruption with subretinal and intraretinal fluid in the left eye (Figure 2(b)). OCT-A (RTVue-XR Avanti, Optovue,
Optical coherence tomography angiography at level of retinal pigment epithelium elevation in right (a) and left (b) eyes demonstrates abnormal flow consistent with choroidal neovascularization.
CRIOPM2017-4754231.003.jpg
PMC5694564_01_CRIOPM2017-4754231.003.jpg
fig3
Fremont, CA) at the level of the RPE disruption in both eyes revealed increased abnormal flow consistent with bilateral CNV (Figure 3). FA (Optos, Optos Inc., Dunfermline, United Kingdom) demonstrated late leakage corresponding to the CNV (Figure 4).
Fluorescein angiography of right (a) and left (b) eyes reveals late leakage posteriorly consistent with choroidal neovascularization.
CRIOPM2017-4754231.004.jpg
PMC5694564_01_CRIOPM2017-4754231.004.jpg
fig4
Fremont, CA) at the level of the RPE disruption in both eyes revealed increased abnormal flow consistent with bilateral CNV (Figure 3). FA (Optos, Optos Inc., Dunfermline, United Kingdom) demonstrated late leakage corresponding to the CNV (Figure 4).